PIWIL2 promotes progression of non-small cell lung cancer by inducing CDK2 and Cyclin A expression

Journal of Translational Medicine

Research

Xi Li¹  Xinwen Zhong¹  Qigang Zhang¹  Xiaohan Qu¹  Jinlu Liu² 

[1] The First Affiliated Hospital, China Medical University, NO. 155, Nanjing North Street, Heping District, 110001, Shenyang, Liaoning, China;The Forth Affiliated Hospital, China Medical University, Shenyang, China;

关键词: PIWIL2;    Non-small cell lung cancer;    Cyclin A;    CDK2;    Prognosis;   

DOI  :  10.1186/s12967-015-0666-y

 received in 2015-04-28, accepted in 2015-09-09,  发布年份 2015

来源: Springer

【 摘 要 】

BackgroundPIWI proteins have important roles in tumorigenesis due to their interaction with piRNAs. Recent studies suggest that PIWI proteins affect prognosis of various cancers.MethodsIn the present study, PIWI genes expression was assayed in non-small cell lung cancer (NSCLC). To determine the effects of PIWIL2 on NSCLC cells, overexpression and interference assays were performed using the A549 and H460 cell lines. The tumor formation model was performed to demonstrate the effects of PIWIL2 on tumor formation in vivo.ResultsPIWIL2 was increased both at the RNA and protein level in malignant cancer tissues compared with adjacent normal tissue. Moreover, increased PIWIL2 gene expression was negatively correlated with prognosis in NSCLC patients. Overexpression and interference of PIWIL2 promoted and depressed cell proliferation, respectively. Meanwhile, PIWIL2 interference arrested cells at the G2/M stage. In addition, we found that CDK2 and Cyclin A expression were correlated with PIWIL2 expression. Moreover, transfection of PIWIL2 promoted tumor growth in nude mice.ConclusionOur findings shed light on the function of PIWIL2 in NSCLC and suggest potential prognostic and therapeutic value.

【 授权许可】

CC BY   
© Qu et al. 2015